'DES daughters' with rare cancer continue to face higher death rates
(Reuters Health) - Women who were exposed to the synthetic estrogen diethylstilbestrol (DES) in utero, and who subsequently developed a rare type of vaginal and cervical cancer, continue to face a higher rate of death between the ages of 35 and 65, according to a new study in the New England Journal of Medicine.
from Reuters: Health News https://reut.rs/2rhgjNn
http://bit.ly/2zwRqiM